Inogen (INGN) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 14, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 13, 2025, or May 7, 2025, for plan shares.

Voting matters and shareholder proposals

• Election of three Class II director nominees: Kevin King, Mary Kay Ladone, and Kevin R.M. Smith, with board recommending a vote for all.

• Ratification of Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2025.

• Advisory vote to approve executive compensation for named executive officers.

• Approval of the Amended and Restated 2023 Equity Incentive Plan.

Board of directors and corporate governance

• Board recommends all director nominees for election to Class II positions.